Zr2-Bioenergy (3)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE has received clarifications from Raymond Ltd, Sanstar Ltd, and Suven Life Sciences Ltd regarding significant price/volume movements. … | |||||||||||||||
BSE has received clarifications from Raymond Ltd, Sanstar Ltd, and Suven Life Sciences Ltd regarding significant price/volume movements. Reply is still awaited from ZR2 Bioenergy Ltd.
| |||||||||||||||
BSE received clarifications from five companies regarding significant price/volume movement observed in their scrips. Reply is still awaited … | |||||||||||||||
BSE received clarifications from five companies regarding significant price/volume movement observed in their scrips. Reply is still awaited from ZR2 Bioenergy Ltd.
| |||||||||||||||
BSE revises price bands for 30 scrips effective March 16, 2026, with bands ranging from 2% to 20% across various equity securities. | |||||||||||||||
BSE revises price bands for 30 scrips effective March 16, 2026, with bands ranging from 2% to 20% across various equity securities. | |||||||||||||||